# FDA recall D-072-2013

> **Ranbaxy Inc.** · Class II · drug recall initiated 2012-11-09.

## Product

Atorvastatin Calcium Tablets, 40 mg, a) 90 tablets per bottle, b) 500 tablets per bottle, Rx only, Manufactured for: Ranbaxy Pharmaceuticals Inc., Jacksonville, FL 32257, USA, by: Ranbaxy Laboratories Ltd., New Delhi - 110019, India, NDC #: a)  63304-829-90, b) 63304-829-05.

## Reason for recall

Presence of Particulate Matter: Certain batches of Atorvastatin tablets 10 mg, 20 mg and 40 mg may contain small glass particulates.

## Distribution

Nationwide and PR

## Key facts

- **Recall number:** D-072-2013
- **Recalling firm:** Ranbaxy Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2012-11-09
- **Report date:** 2012-12-05
- **Termination date:** 2014-04-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Princeton, NJ, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-072-2013

## Citation

> AI Analytics. FDA recall D-072-2013. Retrieved 2026-05-25 from https://api.ai-analytics.org/recall/D-072-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*